• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一名患有AQP2基因新的大片段缺失的复合杂合子的严重先天性肾性尿崩症。病例报告。

Severe congenital nephrogenic diabetes insipidus in a compound heterozygote with a new large deletion of the AQP2 gene. A case report.

作者信息

Peces Ramón, Mena Rocío, Peces Carlos, Santos-Simarro Fernando, Fernández Luis, Afonso Sara, Lapunzina Pablo, Selgas Rafael, Nevado Julián

机构信息

Nephrology Department, La Paz University Hospital, IdiPAZ, Autonomous University, Madrid, Spain.

La Paz University Hospital, Medical and Molecular Genetics Institute (INGEMM), IdiPAZ, Madrid, Spain.

出版信息

Mol Genet Genomic Med. 2019 Apr;7(4):e00568. doi: 10.1002/mgg3.568. Epub 2019 Feb 19.

DOI:10.1002/mgg3.568
PMID:30784238
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6465731/
Abstract

BACKGROUND

Congenital nephrogenic diabetes insipidus (NDI) is a rare condition characterized by severe polyuria, due to the inability of the kidneys to concentrate urine in response to arginine vasopressin (AVP). In the majority of the cases, the disease shows an X-linked inherited pattern, although an autosomal recessive inheritance was also observed.

METHODS

We report a patient with a severe NDI diagnosed during the neonatal period. Because the patient was female without a family history of congenital NDI, her disease was thought to exhibit an autosomal recessive form.

RESULTS

A full mutation analysis of AVP receptor 2 (AVPR2; MIM#300538) gene showed no mutations. However, direct Sanger sequencing of the aquaporin 2 (AQP2) revealed an apparently homozygous mutation at nucleotide position NM_000486.5:c.374C>T (p.Thr125Met) in exon 2. Further customized multiplex ligation-dependent probe amplification (MLPA), single-nucleotide polymorphism (SNP) array analysis, and long-range polymerase chain reaction (PCR) followed by Sanger sequencing showed a heterozygous exonic deletion comprising exons 2, 3, and partially 4 of AQP2.

CONCLUSION

This is the first case of a compound heterozygote patient with a missense mutation involving NM_000486.5:exon2:c.374C>T (p.Thr125Met) and a gross deletion of at least exons 2, 3, and partially 4 on the AQP2 to present with a severe NDI phenotype.

摘要

背景

先天性肾性尿崩症(NDI)是一种罕见病症,其特征为严重多尿,这是由于肾脏无法对精氨酸加压素(AVP)作出反应而浓缩尿液所致。在大多数病例中,该疾病呈X连锁遗传模式,不过也观察到常染色体隐性遗传情况。

方法

我们报告了一名在新生儿期被诊断出患有严重NDI的患者。由于该患者为女性且无先天性NDI家族史,其疾病被认为呈现常染色体隐性形式。

结果

对AVP受体2(AVPR2;MIM#300538)基因进行的全面突变分析未发现突变。然而,对水通道蛋白2(AQP2)进行直接桑格测序显示,在第2外显子的核苷酸位置NM_000486.5:c.374C>T(p.Thr125Met)处存在一个明显的纯合突变。进一步进行定制的多重连接依赖探针扩增(MLPA)、单核苷酸多态性(SNP)阵列分析以及长距离聚合酶链反应(PCR),随后进行桑格测序,结果显示存在一个杂合性外显子缺失,包括AQP2的第2、3外显子以及部分第4外显子。

结论

这是首例患有错义突变(涉及NM_000486.5:外显子2:c.374C>T(p.Thr125Met))和AQP2至少第2、3外显子以及部分第4外显子大片段缺失的复合杂合子患者,该患者表现出严重的NDI表型。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df46/6465731/7f02d672dbe0/MGG3-7-na-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df46/6465731/bcb8f1bfa2ec/MGG3-7-na-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df46/6465731/7f02d672dbe0/MGG3-7-na-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df46/6465731/bcb8f1bfa2ec/MGG3-7-na-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df46/6465731/7f02d672dbe0/MGG3-7-na-g002.jpg

相似文献

1
Severe congenital nephrogenic diabetes insipidus in a compound heterozygote with a new large deletion of the AQP2 gene. A case report.一名患有AQP2基因新的大片段缺失的复合杂合子的严重先天性肾性尿崩症。病例报告。
Mol Genet Genomic Med. 2019 Apr;7(4):e00568. doi: 10.1002/mgg3.568. Epub 2019 Feb 19.
2
Genetic forms of nephrogenic diabetes insipidus (NDI): Vasopressin receptor defect (X-linked) and aquaporin defect (autosomal recessive and dominant).肾性尿崩症(NDI)的遗传形式:血管加压素受体缺陷(X连锁)和水通道蛋白缺陷(常染色体隐性和显性)。
Best Pract Res Clin Endocrinol Metab. 2016 Mar;30(2):263-76. doi: 10.1016/j.beem.2016.02.010. Epub 2016 Mar 2.
3
AQP2: Mutations Associated with Congenital Nephrogenic Diabetes Insipidus and Regulation by Post-Translational Modifications and Protein-Protein Interactions.AQP2:与先天性肾性尿崩症相关的突变及翻译后修饰和蛋白-蛋白相互作用的调节。
Cells. 2020 Sep 26;9(10):2172. doi: 10.3390/cells9102172.
4
Nephrogenic diabetes insipidus.肾性尿崩症
Adv Chronic Kidney Dis. 2006 Apr;13(2):96-104. doi: 10.1053/j.ackd.2006.01.006.
5
Novel mutation of aquaporin-2 gene in a patient with congenital nephrogenic diabetes insipidus.水通道蛋白-2 基因新突变导致先天性肾性尿崩症。
Endocr J. 2009;56(7):905-10. doi: 10.1507/endocrj.k09e-078. Epub 2009 May 20.
6
Hereditary nephrogenic diabetes insipidus in Japanese patients: analysis of 78 families and report of 22 new mutations in AVPR2 and AQP2.日本遗传性肾性尿崩症患者:AVPR2 和 AQP2 中 78 个家系的分析及 22 个新突变的报告。
Clin Exp Nephrol. 2013 Jun;17(3):338-44. doi: 10.1007/s10157-012-0726-z. Epub 2012 Nov 14.
7
Two novel mutations in the aquaporin 2 gene in a girl with congenital nephrogenic diabetes insipidus.一名患有先天性肾性尿崩症女孩的水通道蛋白2基因中的两个新突变。
J Korean Med Sci. 2005 Dec;20(6):1076-8. doi: 10.3346/jkms.2005.20.6.1076.
8
Novel mutations associated with nephrogenic diabetes insipidus. A clinical-genetic study.与肾性尿崩症相关的新型突变。一项临床遗传学研究。
Eur J Pediatr. 2015 Oct;174(10):1373-85. doi: 10.1007/s00431-015-2534-4. Epub 2015 Apr 23.
9
A female with X-linked Nephrogenic diabetes insipidus in a family with inherited central diabetes Insipidus: Case report and review of the literature.家族性中枢性尿崩症伴 X 连锁遗传性肾性尿崩症女性:病例报告及文献复习。
Am J Med Genet A. 2020 May;182(5):1032-1040. doi: 10.1002/ajmg.a.61516. Epub 2020 Feb 19.
10
Mutations in the vasopressin V2 receptor and aquaporin-2 genes in 12 families with congenital nephrogenic diabetes insipidus.12个先天性肾性尿崩症家族中血管加压素V2受体和水通道蛋白-2基因的突变
J Am Soc Nephrol. 1997 Dec;8(12):1855-62. doi: 10.1681/ASN.V8121855.

引用本文的文献

1
A Rare Case of Congenital Nephrogenic Diabetes Insipidus Associated with Aquaporin 2 Gene Mutation and Subsequent Acute Lymphoblastic Leukemia: Impact of Steroids on Kidney Function.一例先天性肾性尿崩症伴水通道蛋白 2 基因突变及随后发生急性淋巴细胞白血病:激素对肾功能的影响。
Am J Case Rep. 2024 May 21;25:e943597. doi: 10.12659/AJCR.943597.
2
Metabolomic Analysis of - Herbal Pair-Improving Nephrotic Syndrome Identifies Activation of IL-13/STAT6 Signaling Pathway.对改善肾病综合征的药对进行代谢组学分析,确定白细胞介素-13/信号转导和转录激活因子6信号通路的激活。
Pharmaceuticals (Basel). 2023 Jan 8;16(1):88. doi: 10.3390/ph16010088.
3

本文引用的文献

1
Hereditary Nephrogenic Diabetes Insipidus: Pathophysiology and Possible Treatment. An Update.遗传性肾性尿崩症:病理生理学和可能的治疗。更新。
Int J Mol Sci. 2017 Nov 10;18(11):2385. doi: 10.3390/ijms18112385.
2
Aquaporin-2: new mutations responsible for autosomal-recessive nephrogenic diabetes insipidus-update and epidemiology.水通道蛋白-2:新的常染色体隐性遗传型肾性尿崩症致病突变及流行病学研究进展。
Clin Kidney J. 2012 Jun;5(3):195-202. doi: 10.1093/ckj/sfs029. Epub 2012 Mar 28.
3
Novel autosomal recessive gene mutations in aquaporin-2 in two Chinese congenital nephrogenic diabetes insipidus pedigrees.
Novel Mutations and Clinical Characteristics in Seven Chinese Families With Congenital Nephrogenic Diabetes Insipidus.
新型突变与 7 个中国先天性肾性尿崩症家系的临床特征
Front Endocrinol (Lausanne). 2021 Jun 10;12:686818. doi: 10.3389/fendo.2021.686818. eCollection 2021.
4
Valine-279 Deletion-Mutation on Arginine Vasopressin Receptor 2 Causes Obstruction in G-Protein Binding Site: A Clinical Nephrogenic Diabetes Insipidus Case and Its Sub-Molecular Pathogenic Analysis.精氨酸加压素受体2上的缬氨酸279缺失突变导致G蛋白结合位点受阻:一例临床肾性尿崩症病例及其亚分子致病分析。
Biomedicines. 2021 Mar 15;9(3):301. doi: 10.3390/biomedicines9030301.
5
Congenital nephrogenic diabetes insipidus due to the mutation in (c.541C>T) in a neonate: A case report.一名新生儿因 (c.541C>T) 突变导致的先天性肾性尿崩症:病例报告。
World J Clin Cases. 2020 Dec 26;8(24):6418-6424. doi: 10.12998/wjcc.v8.i24.6418.
两个中国先天性肾性尿崩症家系中aquaporin-2的新型常染色体隐性基因突变。
Int J Clin Exp Med. 2015 Mar 15;8(3):3629-39. eCollection 2015.
4
Novel mutations associated with nephrogenic diabetes insipidus. A clinical-genetic study.与肾性尿崩症相关的新型突变。一项临床遗传学研究。
Eur J Pediatr. 2015 Oct;174(10):1373-85. doi: 10.1007/s00431-015-2534-4. Epub 2015 Apr 23.
5
Congenital nephrogenic diabetes insipidus with a novel mutation in the aquaporin 2 gene.伴有水通道蛋白2基因新突变的先天性肾性尿崩症
Biomed Rep. 2014 Jul;2(4):596-598. doi: 10.3892/br.2014.283. Epub 2014 May 19.
6
Nephrogenic diabetes insipidus: essential insights into the molecular background and potential therapies for treatment.肾源性尿崩症:对分子背景的基本认识及治疗的潜在疗法。
Endocr Rev. 2013 Apr;34(2):278-301. doi: 10.1210/er.2012-1044. Epub 2013 Jan 29.
7
Hereditary nephrogenic diabetes insipidus in Japanese patients: analysis of 78 families and report of 22 new mutations in AVPR2 and AQP2.日本遗传性肾性尿崩症患者:AVPR2 和 AQP2 中 78 个家系的分析及 22 个新突变的报告。
Clin Exp Nephrol. 2013 Jun;17(3):338-44. doi: 10.1007/s10157-012-0726-z. Epub 2012 Nov 14.
8
Two new large deletions of the AVPR2 gene causing nephrogenic diabetes insipidus and a review of previously published deletions.两种导致肾性尿崩症的 AVPR2 基因的新大片段缺失,并对以往发表的缺失进行了回顾。
Nephrol Dial Transplant. 2012 Oct;27(10):3705-12. doi: 10.1093/ndt/gfs359. Epub 2012 Aug 9.
9
Congenital nephrogenic diabetes insipidus: the current state of affairs.先天性肾性尿崩症:现状。
Pediatr Nephrol. 2012 Dec;27(12):2183-204. doi: 10.1007/s00467-012-2118-8. Epub 2012 Mar 17.
10
Vasopressin-independent targeting of aquaporin-2 by selective E-prostanoid receptor agonists alleviates nephrogenic diabetes insipidus.选择性 E 类前列腺素受体激动剂通过血管加压素非依赖性靶向水通道蛋白-2 来缓解肾性尿崩症。
Proc Natl Acad Sci U S A. 2011 Aug 2;108(31):12949-54. doi: 10.1073/pnas.1104691108. Epub 2011 Jul 18.